STAT

Watch: In never-before-seen video, Purdue’s Richard Sackler defends OxyContin marketing

Purdue's Dr. Richard Sackler was questioned under oath four years ago about his role in the marketing of OxyContin. Now you can watch that deposition.

This story is a collaboration between STAT, ProPublica, and ABC News.

Members of the intensely private Sackler family that controls opioid maker Purdue Pharma are rarely photographed, and even less frequently seen on publicly available videos. Finally, that’s changing.

Four years ago this week, Dr. Richard Sackler sat in a conference room at a law office in a Louisville, Ky., office park. Lawyers for the Kentucky attorney general’s office were taking his

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About Cigna Biosimilar Plans, A Vertex Deal In South Africa, And More
Cigna plans to make copies of AbbVie's Humira arthritis drug available with no out-of-pocket payment to eligible patients in the U.S.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About CVS And Humira Biosimilars, Schumer’s Broken Insulin Promise, And More
New prescriptions for biosimilar versions of Humira, one of the best-selling drugs in the U.S., surged to 36% from just 5% during the first week of April.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About Biocon Eyeing Weight Loss Drugs, Sanofi Layoffs, And More
Biocon is pivoting to weight loss drugs as patents for the blockbuster medicines start to expire, unleashing a coming wave of generics.

Related Books & Audiobooks